MGC Pharmaceuticals is a European based ‘Seed to Medicine’ bio-pharma company focussed on...MGC Pharmaceuticals is a European based ‘Seed to Medicine’ bio-pharma company focussed on developing and commercialising phytocannabinoid derived medicines. The Company’s product offering currently targets two widespread medical conditions – epilepsy and dementia. Based in Europe, MGC Pharma is working to meet the growing demand for affordable high-quality phytocannabinoid medicines globally.More